flag ripk1 Search Results


93
Addgene inc human ripk1
Kinase dead <t>RIPK1</t> D138N mice are not protected from APAP toxicity in vivo while RIPK1 knockdown in RIPK1 D138N mice is protective . A and B , WT and RIPK1 D138N mice were fasted overnight and treated with APAP (300 mg/kg) and euthanized at 24 h. A , serum ALT (U/L). B , representative histology H&E (4x). C and D , RIPK1 D138N mice were treated with RIPK1 or Control ASO five times, subsequently injected with APAP (300 mg/kg) after overnight fast and euthanized at 24 h. C , serum ALT (U/L). D , representative histology H&E (4x). E , WB of RIPK1 and loading control in RIPK1 D138N mice treated with RIPK1 or Control ASO. ∗ p value ≤ 0.05 RIPK1 versus Control ASO treated mice (N = 11–12/group). Results of at least three independent experiments. ALT, alanine aminotransferase; ASO, antisense oligonucleotide; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; RIPK1, receptor interacting protein kinase 1; RIPK1 D138N , RIPK1 kinase dead knock-in mice; WT, wild type.
Human Ripk1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flag+ripk1/pmc07948960-297-0-5?v=Addgene+inc
Average 93 stars, based on 1 article reviews
human ripk1 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

N/A
Full length Clone DNA of Mouse receptor TNFRSF interacting serine threonine kinase 1 with C terminal Flag tag
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

N/A
Full length Clone DNA of Mouse receptor TNFRSF interacting serine threonine kinase 1 with N terminal Flag tag
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

N/A
Full length Clone DNA of Human receptor TNFRSF interacting serine threonine kinase 1 with N terminal Flag tag
  Buy from Supplier

N/A
Full length Clone DNA of Human receptor TNFRSF interacting serine threonine kinase 1 with C terminal Flag tag
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

Image Search Results


Kinase dead RIPK1 D138N mice are not protected from APAP toxicity in vivo while RIPK1 knockdown in RIPK1 D138N mice is protective . A and B , WT and RIPK1 D138N mice were fasted overnight and treated with APAP (300 mg/kg) and euthanized at 24 h. A , serum ALT (U/L). B , representative histology H&E (4x). C and D , RIPK1 D138N mice were treated with RIPK1 or Control ASO five times, subsequently injected with APAP (300 mg/kg) after overnight fast and euthanized at 24 h. C , serum ALT (U/L). D , representative histology H&E (4x). E , WB of RIPK1 and loading control in RIPK1 D138N mice treated with RIPK1 or Control ASO. ∗ p value ≤ 0.05 RIPK1 versus Control ASO treated mice (N = 11–12/group). Results of at least three independent experiments. ALT, alanine aminotransferase; ASO, antisense oligonucleotide; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; RIPK1, receptor interacting protein kinase 1; RIPK1 D138N , RIPK1 kinase dead knock-in mice; WT, wild type.

Journal: The Journal of Biological Chemistry

Article Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

doi: 10.1016/j.jbc.2021.100300

Figure Lengend Snippet: Kinase dead RIPK1 D138N mice are not protected from APAP toxicity in vivo while RIPK1 knockdown in RIPK1 D138N mice is protective . A and B , WT and RIPK1 D138N mice were fasted overnight and treated with APAP (300 mg/kg) and euthanized at 24 h. A , serum ALT (U/L). B , representative histology H&E (4x). C and D , RIPK1 D138N mice were treated with RIPK1 or Control ASO five times, subsequently injected with APAP (300 mg/kg) after overnight fast and euthanized at 24 h. C , serum ALT (U/L). D , representative histology H&E (4x). E , WB of RIPK1 and loading control in RIPK1 D138N mice treated with RIPK1 or Control ASO. ∗ p value ≤ 0.05 RIPK1 versus Control ASO treated mice (N = 11–12/group). Results of at least three independent experiments. ALT, alanine aminotransferase; ASO, antisense oligonucleotide; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; RIPK1, receptor interacting protein kinase 1; RIPK1 D138N , RIPK1 kinase dead knock-in mice; WT, wild type.

Article Snippet: Human RIPK1 was purchased from Addgene (clone # 78,842) and was subsequently tagged with three C-terminal HA tags and subcloned into pCDNA 3.3 using a TOPO TA cloning kit (Thermo Fisher Scientific) according to manufacturer's protocols to yield our 3HA-pCDNA3.3-RIPK1 construct.

Techniques: In Vivo, Knockdown, Control, Injection, Knock-In

Hepatocyte-specific RIPK1 knockout (RIPK1 HepCKO ) protects against APAP toxicity in vivo . RIPK1 flx/flx mice were treated with AAV8-TBG-iCRE or AAV8-TBG-eGFP for hepatocyte-specific knockout (RIPK1 HepCKO ). Ten days later mice were treated with PBS or APAP (300 mg/kg) after overnight fast and euthanized at 1 h, 3 h, (for GSH and NAPQI adducts) or 24 h (for ALT). A , serum ALT U/L at 24 h (N = 12–13/group). B , representative histology H&E (4x). C , WB of RIPK1 and loading control showing protein knockout. D , representative WB of NAPQI protein adducts, densitometry, and loading control, 1 h and 3 h (N = 6/group). E , GSH at 1 h and 3 h using a colorimetric recycling assay expressed as μmoles/gram liver (N = 3/group). ∗ p value ≤0.05 RIPK1 HepCKO versus RIPK1-flx/flx mice ∗∗ p value ≤0.01 RIPK1 HepCKO versus RIPK1-flx/flx. Results of at least three independent experiments. ALT, alanine aminotransferase; APAP, acetaminophen; Flx, Floxed; GFP, green fluorescent protein; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; NAPQI, N-acetyl-p-benzoquinone imine; N.S., not significant; PBS, phosphate buffered saline; RIPK1, receptor interacting protein kinase 1.

Journal: The Journal of Biological Chemistry

Article Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

doi: 10.1016/j.jbc.2021.100300

Figure Lengend Snippet: Hepatocyte-specific RIPK1 knockout (RIPK1 HepCKO ) protects against APAP toxicity in vivo . RIPK1 flx/flx mice were treated with AAV8-TBG-iCRE or AAV8-TBG-eGFP for hepatocyte-specific knockout (RIPK1 HepCKO ). Ten days later mice were treated with PBS or APAP (300 mg/kg) after overnight fast and euthanized at 1 h, 3 h, (for GSH and NAPQI adducts) or 24 h (for ALT). A , serum ALT U/L at 24 h (N = 12–13/group). B , representative histology H&E (4x). C , WB of RIPK1 and loading control showing protein knockout. D , representative WB of NAPQI protein adducts, densitometry, and loading control, 1 h and 3 h (N = 6/group). E , GSH at 1 h and 3 h using a colorimetric recycling assay expressed as μmoles/gram liver (N = 3/group). ∗ p value ≤0.05 RIPK1 HepCKO versus RIPK1-flx/flx mice ∗∗ p value ≤0.01 RIPK1 HepCKO versus RIPK1-flx/flx. Results of at least three independent experiments. ALT, alanine aminotransferase; APAP, acetaminophen; Flx, Floxed; GFP, green fluorescent protein; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; NAPQI, N-acetyl-p-benzoquinone imine; N.S., not significant; PBS, phosphate buffered saline; RIPK1, receptor interacting protein kinase 1.

Article Snippet: Human RIPK1 was purchased from Addgene (clone # 78,842) and was subsequently tagged with three C-terminal HA tags and subcloned into pCDNA 3.3 using a TOPO TA cloning kit (Thermo Fisher Scientific) according to manufacturer's protocols to yield our 3HA-pCDNA3.3-RIPK1 construct.

Techniques: Knock-Out, In Vivo, Control, Saline

RIPK1 HepCKO results in dampening of JNK activation, less p-JNK translocation to the mitochondria, and decreased pMKK4 . RIPK1 flx/flx or RIPK1 HepCKO mice were fasted overnight and treated with APAP 300 mg/kg and euthanized 1 h or 3 h later. A , WB of liver lysates for pJNK, JNK, pMKK4, MKK4, ASK1, and GAPDH as loading control. B , densitometry for pJNK and pMKK4 normalized to their corresponding total protein expression and ASK1 normalized to loading control. C , WB of mitochondrial fraction for pJNK and loading control. D , densitometry of mitochondrial pJNK normalized to loading control. ∗ p value ≤0.05 RIPK1 HepCKO versus RIPK1 flx/flx mice and ∗∗ p value ≤0.01 RIPK1 HepCKO versus RIPK1 flx/flx mice. Flx, Floxed; JNK, c Jun N-terminal kinase; MKK4, mitogen-activated protein kinase 4; ASK1, apoptosis signal regulating kinase 1; RIPK1, receptor interacting protein kinase 1; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PHB1, prohibitin-1; PBS, phosphate buffered saline; APAP, acetaminophen. (N = 4/group). Results of at least three independent experiments.

Journal: The Journal of Biological Chemistry

Article Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

doi: 10.1016/j.jbc.2021.100300

Figure Lengend Snippet: RIPK1 HepCKO results in dampening of JNK activation, less p-JNK translocation to the mitochondria, and decreased pMKK4 . RIPK1 flx/flx or RIPK1 HepCKO mice were fasted overnight and treated with APAP 300 mg/kg and euthanized 1 h or 3 h later. A , WB of liver lysates for pJNK, JNK, pMKK4, MKK4, ASK1, and GAPDH as loading control. B , densitometry for pJNK and pMKK4 normalized to their corresponding total protein expression and ASK1 normalized to loading control. C , WB of mitochondrial fraction for pJNK and loading control. D , densitometry of mitochondrial pJNK normalized to loading control. ∗ p value ≤0.05 RIPK1 HepCKO versus RIPK1 flx/flx mice and ∗∗ p value ≤0.01 RIPK1 HepCKO versus RIPK1 flx/flx mice. Flx, Floxed; JNK, c Jun N-terminal kinase; MKK4, mitogen-activated protein kinase 4; ASK1, apoptosis signal regulating kinase 1; RIPK1, receptor interacting protein kinase 1; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PHB1, prohibitin-1; PBS, phosphate buffered saline; APAP, acetaminophen. (N = 4/group). Results of at least three independent experiments.

Article Snippet: Human RIPK1 was purchased from Addgene (clone # 78,842) and was subsequently tagged with three C-terminal HA tags and subcloned into pCDNA 3.3 using a TOPO TA cloning kit (Thermo Fisher Scientific) according to manufacturer's protocols to yield our 3HA-pCDNA3.3-RIPK1 construct.

Techniques: Activation Assay, Translocation Assay, Control, Expressing, Saline

RIPK1 knockdown and knockout increases A20 protein expression . WT mice were treated with RIPK1 or Control ASO (50 mg/kg) five times, subsequently injected with APAP (300 mg/kg) after fasting and euthanized at 1 h, 2 h, or 4 h. A , representative WB of A20, RIPK1 and loading control. B , RIPK1 flx/flx or RIPK1 HepCKO mice were treated with PBS or APAP (300 mg/kg) after overnight fast and euthanized at 1 h and 3 h. Representative WB of A20, RIPK1 and loading control. C , relative A20 transcript levels normalized to TBP and RIPK1 flx/flx PBS (N = 5/group). ∗∗ p value ≤0.01 RIPK1 HepCKO versus RIPK1 flx/flx . Results of at least three independent experiments. APAP, acetaminophen; ASO, antisense oligonucleotide; CTRL, control; NS, not significant; RIPK1, receptor interacting protein kinase 1; TBP, TATA box binding protein.

Journal: The Journal of Biological Chemistry

Article Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

doi: 10.1016/j.jbc.2021.100300

Figure Lengend Snippet: RIPK1 knockdown and knockout increases A20 protein expression . WT mice were treated with RIPK1 or Control ASO (50 mg/kg) five times, subsequently injected with APAP (300 mg/kg) after fasting and euthanized at 1 h, 2 h, or 4 h. A , representative WB of A20, RIPK1 and loading control. B , RIPK1 flx/flx or RIPK1 HepCKO mice were treated with PBS or APAP (300 mg/kg) after overnight fast and euthanized at 1 h and 3 h. Representative WB of A20, RIPK1 and loading control. C , relative A20 transcript levels normalized to TBP and RIPK1 flx/flx PBS (N = 5/group). ∗∗ p value ≤0.01 RIPK1 HepCKO versus RIPK1 flx/flx . Results of at least three independent experiments. APAP, acetaminophen; ASO, antisense oligonucleotide; CTRL, control; NS, not significant; RIPK1, receptor interacting protein kinase 1; TBP, TATA box binding protein.

Article Snippet: Human RIPK1 was purchased from Addgene (clone # 78,842) and was subsequently tagged with three C-terminal HA tags and subcloned into pCDNA 3.3 using a TOPO TA cloning kit (Thermo Fisher Scientific) according to manufacturer's protocols to yield our 3HA-pCDNA3.3-RIPK1 construct.

Techniques: Knockdown, Knock-Out, Expressing, Control, Injection, Binding Assay

Mice with hepatocyte-specific knockout of A20 (A20 HepCKO ) display worse liver injury following APAP compared with littermate controls (A20 flx/flx ) . A20 flx/flx mice were treated with AAV8-TBG-iCRE or AAV8-TBG-eGFP for hepatocyte-specific knockout (A20 HepCKO ), after 7 days mice were fasted overnight and treated with APAP 300 mg/kg and euthanized 3 h or 24 h later. A , serum ALT U/L at 24 h (N = 10–11/group). B , representative Histology H&E (4x). C , representative WB of liver lysates for A20 and loading control. D , representative WB of RIPK1 and loading control. E , representative WB of NAPQI protein adducts, densitometry, and loading control (N = 4/group). F , GSH using a colorimetric recycling assay expressed as μmoles/gram liver. (N = 3/group). ∗ p value ≤0.05 A20 HepCKO versus A20-flx/flx mice. Results of at least three independent experiments. ALT, alanine aminotransferase; APAP, acetaminophen; Flx, floxed; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; NAPQI, N-acetyl-p-benzoquinone imine; N.S., not significant; PBS, phosphate buffered saline; RIPK1, receptor interacting protein kinase-1.

Journal: The Journal of Biological Chemistry

Article Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

doi: 10.1016/j.jbc.2021.100300

Figure Lengend Snippet: Mice with hepatocyte-specific knockout of A20 (A20 HepCKO ) display worse liver injury following APAP compared with littermate controls (A20 flx/flx ) . A20 flx/flx mice were treated with AAV8-TBG-iCRE or AAV8-TBG-eGFP for hepatocyte-specific knockout (A20 HepCKO ), after 7 days mice were fasted overnight and treated with APAP 300 mg/kg and euthanized 3 h or 24 h later. A , serum ALT U/L at 24 h (N = 10–11/group). B , representative Histology H&E (4x). C , representative WB of liver lysates for A20 and loading control. D , representative WB of RIPK1 and loading control. E , representative WB of NAPQI protein adducts, densitometry, and loading control (N = 4/group). F , GSH using a colorimetric recycling assay expressed as μmoles/gram liver. (N = 3/group). ∗ p value ≤0.05 A20 HepCKO versus A20-flx/flx mice. Results of at least three independent experiments. ALT, alanine aminotransferase; APAP, acetaminophen; Flx, floxed; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; NAPQI, N-acetyl-p-benzoquinone imine; N.S., not significant; PBS, phosphate buffered saline; RIPK1, receptor interacting protein kinase-1.

Article Snippet: Human RIPK1 was purchased from Addgene (clone # 78,842) and was subsequently tagged with three C-terminal HA tags and subcloned into pCDNA 3.3 using a TOPO TA cloning kit (Thermo Fisher Scientific) according to manufacturer's protocols to yield our 3HA-pCDNA3.3-RIPK1 construct.

Techniques: Knock-Out, Control, Saline

A20 HepCKO results in sustained JNK activation through increased ASK1 protein . A20 flx/flx or A20 HepCKO mice were fasted overnight and treated with APAP 300 mg/kg and euthanized 3 h later. A , WB of liver lysates for p JNK, JNK, pMKK4, MKK, ASK1, and GAPDH as loading control. B , densitometry for pJNK and pMKK4 normalized to their total protein expression and ASK1 normalized to loading control. C , WB of mitochondrial fraction for pJNK and PHB1, loading control. D , densitometry is shown as mitochondrial pJNK normalized to PHB1 loading control. E , relative transcript levels of ASK1 normalized to TBP and RIPK1 flx/flx PBS (N = 5/group). ∗ p value ≤0.05 A20 HepCKO versus A20-flx/flx mice; ∗∗ p value ≤0.01 A20 HepCKO versus A20-flx/flx mice. (N = 4/group). Results of at least three independent experiments. APAP, acetaminophen; ASK1, apoptosis signal regulating kinase 1; Flx, floxed; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; JNK, c Jun N-terminal kinase; MKK4, mitogen-activated protein kinase 4; PBS, phosphate buffered saline; PHB1, prohibitin-1.

Journal: The Journal of Biological Chemistry

Article Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

doi: 10.1016/j.jbc.2021.100300

Figure Lengend Snippet: A20 HepCKO results in sustained JNK activation through increased ASK1 protein . A20 flx/flx or A20 HepCKO mice were fasted overnight and treated with APAP 300 mg/kg and euthanized 3 h later. A , WB of liver lysates for p JNK, JNK, pMKK4, MKK, ASK1, and GAPDH as loading control. B , densitometry for pJNK and pMKK4 normalized to their total protein expression and ASK1 normalized to loading control. C , WB of mitochondrial fraction for pJNK and PHB1, loading control. D , densitometry is shown as mitochondrial pJNK normalized to PHB1 loading control. E , relative transcript levels of ASK1 normalized to TBP and RIPK1 flx/flx PBS (N = 5/group). ∗ p value ≤0.05 A20 HepCKO versus A20-flx/flx mice; ∗∗ p value ≤0.01 A20 HepCKO versus A20-flx/flx mice. (N = 4/group). Results of at least three independent experiments. APAP, acetaminophen; ASK1, apoptosis signal regulating kinase 1; Flx, floxed; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; JNK, c Jun N-terminal kinase; MKK4, mitogen-activated protein kinase 4; PBS, phosphate buffered saline; PHB1, prohibitin-1.

Article Snippet: Human RIPK1 was purchased from Addgene (clone # 78,842) and was subsequently tagged with three C-terminal HA tags and subcloned into pCDNA 3.3 using a TOPO TA cloning kit (Thermo Fisher Scientific) according to manufacturer's protocols to yield our 3HA-pCDNA3.3-RIPK1 construct.

Techniques: Activation Assay, Control, Expressing, Saline

A20 Coimmunoprecipitates with RIPK1 and ASK1 in vitro . A , HEK293T cells were cotransfected to overexpress HA-RIPK1 and A20-Flag for 24 h. Cells were harvested and IP was performed with HA Tag, Flag Tag, or isotype matched control IgG. Membranes were immunoblotted for A20 and RIPK1. B , HEK293T cells were cotransfected to overexpress the kinase dead mutant HA- RIPK1 D138N and A20-Flag for 24 h, and subsequently lysates were IPed with HA Tag, Flag Tag, or isotype control IgG. Membranes were immunoblotted for A20 and RIPK1. C , HEK293T cells were cotransfected to overexpress GFP-A20 and ASK1-Flag for 24 h, and subsequently IP was performed with GFP Tag, Flag Tag, or isotype control IgG. Membranes were immunoblotted for A20 and ASK1. D , HEK293T cells were cotransfected to overexpress ASK1-Flag and HA-RIPK1 or control IgG for 24 h. Lysates were IPed with HA tag and immunoblotted against ASK1and RIPK1. Results of at least three independent experiments.

Journal: The Journal of Biological Chemistry

Article Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

doi: 10.1016/j.jbc.2021.100300

Figure Lengend Snippet: A20 Coimmunoprecipitates with RIPK1 and ASK1 in vitro . A , HEK293T cells were cotransfected to overexpress HA-RIPK1 and A20-Flag for 24 h. Cells were harvested and IP was performed with HA Tag, Flag Tag, or isotype matched control IgG. Membranes were immunoblotted for A20 and RIPK1. B , HEK293T cells were cotransfected to overexpress the kinase dead mutant HA- RIPK1 D138N and A20-Flag for 24 h, and subsequently lysates were IPed with HA Tag, Flag Tag, or isotype control IgG. Membranes were immunoblotted for A20 and RIPK1. C , HEK293T cells were cotransfected to overexpress GFP-A20 and ASK1-Flag for 24 h, and subsequently IP was performed with GFP Tag, Flag Tag, or isotype control IgG. Membranes were immunoblotted for A20 and ASK1. D , HEK293T cells were cotransfected to overexpress ASK1-Flag and HA-RIPK1 or control IgG for 24 h. Lysates were IPed with HA tag and immunoblotted against ASK1and RIPK1. Results of at least three independent experiments.

Article Snippet: Human RIPK1 was purchased from Addgene (clone # 78,842) and was subsequently tagged with three C-terminal HA tags and subcloned into pCDNA 3.3 using a TOPO TA cloning kit (Thermo Fisher Scientific) according to manufacturer's protocols to yield our 3HA-pCDNA3.3-RIPK1 construct.

Techniques: In Vitro, FLAG-tag, Control, Mutagenesis

RIPK1 interferes with the A20-ASK1 interaction by binding to and sequestering A20 in vitro . A , HEK293T cells were cotransfected to overexpress GFP-A20 and ASK1-Flag either with HA-RIPK1 or control vector for 24 h. Cells were harvested and IP was performed with GFP Tag or isotype-matched control IgG. Membranes were immunoblotted for ASK1, A20, and RIPK1. B , HEK293T cells were cotransfected to overexpress GFP-A20 and ASK1-Flag either with HA-RIPK1 or control vector for 24 h, and subsequently lysates were IPed with Flag Tag or isotype-matched control IgG. Membranes were immunoblotted for A20, ASK1, and RIPK1.

Journal: The Journal of Biological Chemistry

Article Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

doi: 10.1016/j.jbc.2021.100300

Figure Lengend Snippet: RIPK1 interferes with the A20-ASK1 interaction by binding to and sequestering A20 in vitro . A , HEK293T cells were cotransfected to overexpress GFP-A20 and ASK1-Flag either with HA-RIPK1 or control vector for 24 h. Cells were harvested and IP was performed with GFP Tag or isotype-matched control IgG. Membranes were immunoblotted for ASK1, A20, and RIPK1. B , HEK293T cells were cotransfected to overexpress GFP-A20 and ASK1-Flag either with HA-RIPK1 or control vector for 24 h, and subsequently lysates were IPed with Flag Tag or isotype-matched control IgG. Membranes were immunoblotted for A20, ASK1, and RIPK1.

Article Snippet: Human RIPK1 was purchased from Addgene (clone # 78,842) and was subsequently tagged with three C-terminal HA tags and subcloned into pCDNA 3.3 using a TOPO TA cloning kit (Thermo Fisher Scientific) according to manufacturer's protocols to yield our 3HA-pCDNA3.3-RIPK1 construct.

Techniques: Binding Assay, In Vitro, Control, Plasmid Preparation, FLAG-tag

Proposed signaling mechanism. After APAP, ASK1 is activated (pASK1) and results in the activation of MKK4 (pMKK4), pJNK, and liver injury . Knockout of RIPK1 in hepatocytes leads to increased A20 levels, which allow for A20 to bind, sequester, and possibly inactivate or degrade ASK1, thus yielding a downregulation of pMKK4 and pJNK, which ultimately result in an attenuation in liver injury. Conversely, in hepatocyte-specific A20 knockout livers, ASK1 protein is increased, leading to phospho-activation of MKK4 and sustained pJNK activation, which result in increased liver injury.

Journal: The Journal of Biological Chemistry

Article Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

doi: 10.1016/j.jbc.2021.100300

Figure Lengend Snippet: Proposed signaling mechanism. After APAP, ASK1 is activated (pASK1) and results in the activation of MKK4 (pMKK4), pJNK, and liver injury . Knockout of RIPK1 in hepatocytes leads to increased A20 levels, which allow for A20 to bind, sequester, and possibly inactivate or degrade ASK1, thus yielding a downregulation of pMKK4 and pJNK, which ultimately result in an attenuation in liver injury. Conversely, in hepatocyte-specific A20 knockout livers, ASK1 protein is increased, leading to phospho-activation of MKK4 and sustained pJNK activation, which result in increased liver injury.

Article Snippet: Human RIPK1 was purchased from Addgene (clone # 78,842) and was subsequently tagged with three C-terminal HA tags and subcloned into pCDNA 3.3 using a TOPO TA cloning kit (Thermo Fisher Scientific) according to manufacturer's protocols to yield our 3HA-pCDNA3.3-RIPK1 construct.

Techniques: Activation Assay, Knock-Out